We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Spread of MRSA Linked to Readily Transferred Genetic Element

By LabMedica International staff writers
Posted on 30 Apr 2012
A recent paper demonstrated the key role played by a rare mobile genetic element in the spread of methicillin-resistant Staphylococcus aureus (MRSA).

MRSA is any strain of S. More...
aureus that has developed resistance to beta-lactam antibiotics, which include the penicillins (methicillin, dicloxacillin, nafcillin, oxacillin, etc.) and the cephalosporins.

In a recent study, investigators at the [US] National Institutes of Health (Bethesda, MD, USA) worked with MRSA clones containing what had been assumed to be an extremely rare mobile genetic element–encoded gene, sasX. However, they reported in the April 22, 2012, online edition of the journal Nature Medicine that after analyzing 807 patient samples from three Chinese hospitals they had found that sasX was more prevalent in MRSA strains from China than previously thought. The gene's frequency was increasing significantly: from 2003 to 2011, the percentage of MRSA samples containing sasX almost doubled, from 21 to 39%.

Experiments conducted with cell cultures and with populations of laboratory mice showed that sasX had a key role in MRSA colonization and pathogenesis, substantially enhancing nasal colonization, lung disease, and abscess formation and promoting mechanisms of immune evasion.

The investigators stated that their results vindicated the theory that the emergence of new clones of highly virulent MRSA occurs through horizontal gene transfer, the exchange of DNA between different strains. This was evidenced by observations of transfer of sasX from the ST239 Chinese strain to MRSA clones other than those belonging to this group.

Senior author Dr. Michael Otto, an investigator at the [US] National Institutes of Health, predicted that the frequency of sasX would increase internationally. Plans have been prepared monitor its spread and to develop therapeutics to limit the damage caused by sasX-expressing MRSA strains.

Related Links:

National Institutes of Health



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automated Staining Unit
RAL Stainer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.